E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/3/2014 in the Prospect News PIPE Daily.

Quotient to price IPO of 5 million shares between $14.00 and $16.00

UBS Investment Bank, Baird and Cowen will be the joint bookrunners

By Devika Patel

Knoxville, Tenn., April 3 - Quotient Ltd. will sell 5 million ordinary shares in its initial public offering with a 30-day greenshoe of 750,000 additional shares, according to a Form S-1/A filed Thursday with the Securities and Exchange Commission. The deal was announced March 7.

The shares will be sold at a price expected to fall between $14.00 and $16.00 per share.

UBS Securities LLC, Robert W. Baird & Co. Inc. and Cowen and Co. LLC are the joint bookrunning managers.

Proceeds will be used for the conversion of a facility in Eysins, Switzerland, to manufacture MosaiQ consumables, and for general corporate purposes.

The diagnostics company is based in Midlothian, England. The company intends to list its common stock on the Nasdaq stock exchange under the symbol "QTNT."


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.